The World Health Organization (WHO) on Friday warned against the anti-viral drug remadecivir being used in various hospitals against corona virus patients. The WHO claims that no evidence has been found of corona patients with mild or severe symptoms from remdesvir.
The latest guidelines state that the panel has not found any such evidence of remdesive, which suggests that the drug may have reduced mortality or that patients may have needed mechanical ventilation after its use. Remadecivir was first created for the Ebola virus, but the drug could not achieve much success.
Subsequently, ten of the drug also began to be used on corona virus patients. Some trials also led to better results. Because of this, the drug remadacevir was used to cure corona patients in many countries of the world. It is currently being used only in emergency cases in India and has not received full clearance.
Last month’s trial of the WHO revealed that the drug had little or no effect on corona patients. The WHO’s latest guidelines are a major setback for the pharmaceutical company. The WHO’s Guideline Development Group (GDG) panel said its recommendation is based on an evidence review, which includes data from more than 7,000 patients on trial.
ALSO READ: The risk of death of corona patients with the drug Remedisiver reduced by 62%: Study